leadership change at teva provides catalyst , page-6

Hi Dolce - I understand your anxiousness with current market not helping.MSB is well supported by institutional funds ( >90%)which IMO, really helps in this market.

IMO, an update couldnt be too far away...and it could be any of the following:

*Commencement of Diabetes trials in Humans;
*Spinal Fusion trials
*Pre-clinical intraveneous trials on other applications
*BMT phase III commencement
*FDA update on CHF Phase III
*Update on European Heart Attack Trials.

Its all about the science with MSB ...NO 1 key factor.
Reading over Stuart Roberts (Bells) update last November 2011 - he believes he has "seen the future and it works ". I think TEVA and LONZA share his view.

So happy to be invested in the blaster.

Good luck to all holders.
DYOR.